Abstract. Interstitial cells of Cajal (ICCs) function as pacemaker cells in the gastrointestinal (GI) tract and therefore, serve an important role in regulating GI motility. The effects of a species of plum (Prunus mume Siebold & Zucc.) on cultured ICC cluster-induced pacemaker potentials in the mouse small intestine were investigated, and the effects of a methanolic extract of Prunus mume (m-PM) on ICC pacemaker activities were examined using the whole-cell patch-clamp technique. ICC pacemaker membrane potentials were depolarized by m-PM in a concentration dependent manner in current clamp mode. 4-Diphenylacetoxy-N-methyl-piperidine methiodide, which is a muscarinic 3 (M 3 ) receptor antagonist, was able to block m-PM-induced pacemaker potential increases, whereas methoctramine, which is a muscarinic 2 (M 2 ) receptor antagonist, was not. When 1 mM guanosine diphosphate β-5 was present in the pipette solution, m-PM induced slight pacemaker depolarization. Following pretreatment in bath solution of Ca 2+ -free solution or a Ca 2+ -ATPase inhibitor in endoplasmic reticulum, the pacemaker currents were inhibited. Furthermore, pretreatment with PD98059, SB203580 or SP600125, which is a c-jun NH2-terminal kinase inhibitor, blocked m-PM-induced ICC potential depolarization. Furthermore, m-PM inhibited transient receptor potential melastatin (TRPM) 7 channels, but did not affect Ca 2+ -activated Cl -channels. These results suggest that m-PM is able to modulate pacemaker potentials through the muscarinic M 3 receptor, via G-protein and external and internal Ca 2+ , in a mitogen-activated protein kinase and TRPM7-dependent manner. Therefore, m-PM may provide a basis for the development of a novel gastroprokinetic agent.
Introduction
The fruit of the plum tree Prunus mume Siebold & Zucc. (PM) is used across East Asia, particularly in Korea and Japan (1) , as a traditional herbal medicine for the relief of digestive problems, fatigue and fever. PM contains a number of phenolic compounds, including phenolic acids and flavonoids (1, 2) , which have antioxidant and free radical scavenging activities in vivo (3) (4) (5) (6) . Furthermore, PM extracts exhibit many pharmacological activities, including antimicrobial (7-10), immune enhancing (11) , anti-cancer (1, 12, 13) , and anti-fatigue (14) effects, and have been demonstrated to enhance osteoclast differentiation (15) and improve blood flow (16). Additionally, previous studies have reported that using PM extracts with probiotics inhibits the development of atopic dermatitis (17) and enhances immunity (18) .
Interstitial cells of Cajal (ICCs) are the pacemakers of the gastro-intestinal tract and generate rhythmic responses in cell membrane electrical potentials (19, 20) , thus serving important roles in the regulation of GI motility (21) . Additionally, endogenous agents are able to regulate GI motility function via ICCs (22) (23) (24) (25) . Furthermore, transient receptor potential melastatin (TRPM) 7 (26) or Cl -channels, such as anoctamin1 (ANO1) (27) (28) (29) , are associated with pacemaker potentials in the GI tract. Therefore, TRPM7 and ANO1 may be therapeutic targets for the treatment of GI motility disorders.
It has been reported previously that PM is able to enhance the propulsive motion and motility of the small intestine (7) and promote the frequency of defecation and colon contraction in rats, which supports the potential role of PM as a therapeutic agent for the treatment of constipation (30) . However, little is known about the effect of PM on ICC clusters in the GI tract. The aims of the present study were to evaluate the effects of the methanoic extract of PM (m-PM) on the electrical pacemaker potentials of cultured ICCs and characterize m-PM-mediated signaling pathways. ; humidity, 50±5%; 12 h light/dark cycles) and were allowed free access to food and water. Small intestines were removed and opened along the mesenteric border, and luminal contents were removed via washing with Krebs-Ringer bicarbonate solution. Sharp dissection was performed to remove small intestine mucosae and small strips of intestine muscle were subsequently equilibrated in Ca 2+ -free physiological salt solution (in mmol/l: 125 NaCl, 5.36 KCl, 0.34 NaOH, 0.44 Na 2 HCO 3 , 10 glucose, 2.9 sucrose, and 11 HEPES buffer) for 20 min and dispersed using an enzyme solution containing 1.5 mg/ml collagenase (Worthington Biochemical Corp., Lakewood, NJ, USA), 2.5 mg/ml bovine serum albumin (Sigma-Aldrich; Merck Millipore), 2.5 mg/ml trypsin inhibitor (Sigma-Aldrich; Merck Millipore) and 0.5 mg/ml adenosine triphosphate (ATP) (Sigma-Aldrich; Merck Millipore). Cells were plated on glass coverslips coated with 0.01% poly-L-lysine solution (Sigma-Aldrich; Merck Millipore) and cultured in an atmosphere containing 95% O 2 and 5% CO 2 in smooth muscle basal medium (Clonetics Corp.; Lonza, Walkersville, MA, USA) supplemented with stem cell factor (5 ng/ml; Sigma-Aldrich; Merck Millipore) and 1% penicillin/streptomycin (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37˚C.
Effects of Prunus mume
Whole cell patch-clamp experiments. The Na + -Tyrode solution used in bath solution contained 135 mM NaCl, 5 mM KCl, 135 mM NaCl, 2 mM CaCl 2 , 10 mM glucose, 1.2 mM MgCl 2 and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, adjusted to pH 7.4 with NaOH. A pipette solution was also used, which contained 140 mM KCl, 5 mM MgCl 2 , 2.7 mM K 2 ATP, 0.1 mM Na guanosine triphosphate (GTP), 2.5 mM creatine phosphate disodium, 5 mM HEPES buffer and 0.1 mM ethylene glycol bis (2-aminoethyl ether)-N, N,N',N'-tetraacetic acid (EGTA), adjusted to pH 7.2 with KOH. The whole-cell patch-clamp technique was performed to record the membrane electrical potentials in cultured ICCs and membrane potentials were amplified using an Axopatch 1-D (Molecular Devices, LLC, Sunnyvale, CA, USA). Command pulses were applied using a Samsung-compatible personal computer and pClamp software (ver. 9.0; Molecular Devices). Data were filtered at 1 kHz and displayed on a computer monitor. pClamp and Origin software (ver. 8.0; MicroCal, Northampton, MA, USA) were used for statistical analysis. All experiments were performed at 30˚C.
TRPM7 overexpression. Human embryonic kidney (HEK)-293 cells (American Type Culture Collection, Manassas, VA, USA) were transfected with Flag-murine LTRPC7/pCDNA4-TO construct and subsequently cultured in Dulbecco's Modified Eagle medium (Thermo Fisher Scientific, Inc.) supplemented with 5 µg/ml blasticidin, 0.4 mg/ml zeocin and 10% fetal bovine serum (Thermo Fisher Scientific, Inc.). Adding 1 µg/ml tetracycline to the medium for 24 h induced TRPM7 overexpression. HEK293 cells overexpressing TRPM7 were bathed in a solution containing 145 mM NaCl, 2.8 mM KCl, 2 mM CaCl 2 , 10 mM glucose, 1.2 mM MgCl 2 and 10 mM HEPES buffer, adjusted to pH 7.4 with NaOH. The pipette solution contained 145 mM Cs-glutamate, 8 mM NaCl, 10 mM Cs-2-bis (2-aminophenoxy)-ethane-N,N,N' ,N'-tetraacetic acid, and 10 mM HEPES-CsOH, adjusted to pH 7.3 with CsOH.
Ca
2+ activated Cl -channel overexpression. HEK-293 cells were transfected with the pEGFP-N1-mANO1 construct for 24 h and these cells were cultured on glass coverslips in Dulbecco's Modified Eagle medium, which was supplemented with 10% fetal bovine serum. The bath solution contained 146 mM HCl, 10 mM HEPES, 10 mM glucose, 1 mM MgCl 2 , 1 mM CaCl 2 and 150 mM N-methyl-D-glucamine (NMDG), adjusted to pH 7.4. The pipette solution contained 150 mM NMDG-Cl, 1 mM MgCl 2 , 3 mM MgATP, 10 mM EGTA, 5 mM CaCl 2 and 5 mM HEPES buffer at pH 7.2 (titrated with NMDG). WEBMAX-C STANDARD software (C. Patton, Stanford University, www.stanford.edu/~cpatton/maxc.html) was used to fix the free calcium concentration at 200 nM.
Pharmacological agents. Pharmacological agents, including methoctramine, 4-diphenylacetoxy-N-methyl-piperidine methiodide (4-DAMP), guanosine 5'-O-(2-thiodiphosphate) (GDP-β-S), thapsigargin, PD98059, SB203580 and SP600125, were purchased from Sigma-Aldrich (Merck Millipore). They were dissolved in dimethyl sulfoxide (DMSO) or distilled water and stored at -20˚C. The final concentration of DMSO in the bath solution was maintained at <0.1%.
Statistical analysis.
Results are expressed as mean ± standard error of the means. Student's t-test for unpaired data was performed to compare control and experimental groups. Origin software (version 8.0; OriginLab, Northampton, MA, USA) was used to perform statistical analysis. P<0.05 was considered to indicate a statistically significant difference.
Results

Effect of m-PM on pacemaker electrical potentials in cultured
ICCs. The effect of m-PM on pacemaker electrical potentials in cultured ICCs was investigated. Mean resting electrical potential of membranes was -51.7±2.4 mV and the electrical amplitude was 21.6±2.3 mV. Following m-PM administration (50-500 µg/ml), mean membrane electrical potentials were depolarized to 6.2±1.3 (50 µg/ml), 10.6±1.2 (100 µg/ml), 18.5±1.5 (300 µg/ml) and 30.3±1.6 mV (500 µg/ml; Fig. 1A-E) , and corresponding amplitudes decreased to 17.3±0.6, 11.4±1.5, 6.7±0.8, and 3.3±0.5 mV, respectively (Fig. 1B-E) . The effects of m-PM on pacemaker electrical potentials are presented in Fig. 1F and G (n=7). These results suggest that m-PM modulates the pacemaker potentials of ICCs.
m-PM receptors in cultured ICCs.
To study the m-PM receptors on ICCs, muscarinic receptors were investigated as they mediate membrane electrical depolarization in the GI tract (32, 33) . Furthermore, it has been demonstrated that ICCs express M 2 and M 3 muscarinic receptors in the GI tract (34) . Pretreatment with muscarinic receptor antagonists was performed to identify which muscarinic receptor was associated with the response. Membranes were pretreated with 10 µm methoctramine, which is a muscarinic M 2 receptor antagonist, or 4-DAMP, which is a muscarinic M 3 receptor antagonist, for 5 min prior to m-PM (300 µg/ml) administration. Neither antagonist had any effect on pacemaker potentials. Methoctramine did not inhibit the effect of m-PM ( Fig. 2A) , whereas 4-DAMP was able to inhibit m-PM-induced membrane depolarization (Fig. 2B) . The mean membrane electrical depolarization by m-PM following pretreatment with methoctramine or 4-DAMP was 17.5±0.7 and 0.9±0.4 mV, respectively (n=5 in each; Fig. 2C ). These results indicate that m-PM affects ICCs through M 3 receptors, not M 2 receptors.
Association between G proteins and m-PM-induced pacemaker electrical potentials in cultured ICCs
. GDP-β-S, which permanently inactivates G-protein binding proteins (35, 36) , was administered to determine whether G-proteins are associated with the effects of m-PM on cultured ICCs. m-PM (300 µg/ml) induced ICC membrane depolarization (Fig. 1D) ; however, when GDP-β-S (1 mM) was present in the pipette solution, m-PM-induced depolarization was markedly reduced (n=5; Fig. 3 ). These results suggest that G-proteins have a role in the m-PM-induced pacemaker depolarization of ICCs. (37) . To investigate the roles of external and internal Ca 2+ on m-PM-induced pacemaker depolarizations, m-PM was applied in the absence of external Ca 2+ and in the presence of thapsigargin (a Ca 2+ -ATPase inhibitor in endoplasmic reticulum). When exposed to the external 
Effects of external
Ca
2+ -free condition, pacemaker potentials were abolished and were unaffected by the administration of m-PM (Fig. 4A) . Pretreatment with thapsigargin (5 µM) also suppressed pacemaker electrical potentials and in these conditions, m-PM had no effect on pacemaker electrical potentials (Fig. 4B) . The effects of m-PM on pacemaker electrical potentials are presented in Fig. 4C (n=6) . These results suggest external Ca 2+ or internal Ca 2+ regulations modulate m-PM-induced pacemaker electrical potentials in cultured ICCs.
Association of mitogen-activated protein kinase (MAPKs) with m-PM-induced pacemaker potentials of cultured ICCs.
To evaluate the mechanisms involved in the interaction between m-PM and M 3 receptors, the role of mitogen-activated protein kinases (MAPKs) was investigated. It has been demonstrated that muscarinic receptors are able to activate MAPKs in various cell types (38, 39) ; therefore, the potential role of MAPKs in regulating the effects of m-PM was determined by administrating a p42/44 MAPK inhibitor (PD98059), a p38 MAPK inhibitor (SB203580) or a c-jun NH2-terminal kinase (JNK) II inhibitor (SP600125). PD98059 (10 µM), m-PM did not induce membrane electrical depolarization (Fig. 5A) . m-PM-induced membrane electrical depolarization was partially blocked by the administration of SB203580 (Fig. 5B) and completely blocked by the administration of SP600125 (Fig. 5C) . The effects of m-PM on pacemaker electrical potentials are presented in Fig. 5D (n=5) . These results suggest that MAPKs modulate m-PM-induced pacemaker electrical potentials in cultured ICCs.
Association of TRPM7 and Ca
2+ -activated Cl -channels with m-PM-induced pacemaker potentials in cultured ICCs. In the murine small intestine, pacemaker potentials are predominantly induced by the activation of non-selective cation channels (25, 26) or Cl -channels (27) (28) (29) . To determine which channel is associated with the m-PM-induced depolarization of pacemaker potentials, the effects of m-PM on TRPM7 and Ca 2+ -activated Cl -channels were examined. Membranes were transfected with the FLAG-murine TRPM7/pCDNA4/TO construct using Lipofectamine 2000 (Thermo Fisher Scientific, Inc.) and ~90% of cells were transfected. In a previous study, TRPM7-transfected HEK293 cells induced by tetracycline produced a flag-reactive band with a relative molecular mass of 220 kilodaltons (21) . Another study revealed that ANO1 channels were overexpressed in HEK293 cells transfected with an ANO1 construct (40) and whole cell currents were recorded using patch-clamp techniques. In the present study, TRPM7 and ANO1 currents were activated in mock transfected cells (Fig. 6A and B) and it was demonstrated that m-PM inhibited the activities of TRPM7 channels, but did not affect the Ca 2+ -activated Cl -ANO1 channels (n=4; Fig. 6C-F) , thus indicating that the effects of m-PM are attributable to TRPM7 channels.
Discussion
In the present study, it was demonstrated that administration of m-PM induced depolarization of ICC pacemaker potentials through muscarinic M 3 receptor signaling pathways in a G protein-MAPK dependent manner. Furthermore, m-PM was able to inhibit TRPM7 currents, indicating that TRPM7 is associated with the m-PM-induced membrane depolarization of ICCs.
In intestinal motility, PM has been reported to enhance propulsive motion and small intestine motility, as determined by the coated charcoal method (7) . Additionally, it has been demonstrated that PM has laxative effects in constipation rat models, as it accelerated the spontaneous contraction of isolated colon (30) . Furthermore, citric and malic acid, the major organic acids in plums, stimulate spontaneous contractions in the colon (30) . These findings support the commonly held belief that plums help to prevent constipation and that ICCs function as pacemakers in the small intestine thus modulating GI motility. In the present study, it was identified that m-PM depolarizes ICC pacemaker activity.
The authors of the present study have previously investigated the effects of traditional medicines on pacemaker electrical potentials in ICCs. It has been determined that Poncirus fructus (PF) is able to modulate pacemaker electrical potentials via the 5-hydroxytryptamine (5-HT) 3 and 5-HT 4 receptor pathways in a MAPK-dependent manner (24) and gintonin-mediated membrane depolarization and Ca 2+ -activated Cl -channel activation have been observed in cultured murine ICCs via a lysophosphatidic acid 1/3 receptor signaling pathway (41) . Additionally, it was determined that San-Huang-Xie-Xin-tang (SHXXT) is able to modulate pacemaker electrical potentials (42) . The results of in vivo experiments suggested that SHXXT-regulated GI motility was due to the activities of Coptidis rhizome and Rhei rhizome (42) . Furthermore, Schisandra chinensis (Turcz.) Baill. extract (SC extract) was determined to modulate ICC pacemaker potentials via external and internal Ca 2+ regulation, and via G protein and the phospholipase C (PLC) pathway, in a dose-dependent manner, and increased intestinal transit rates in mouse models of normal and abnormal GI motility (43) . These studies indicate that traditional medicines, such as PF, ginseng, SHXXT and SC may potentially be used as gastroprokinetic agents. The results of the present study demonstrated that m-PM exhibited the potential of a prokinetic agent for GI motility dysfunctions.
The MAPK family of protein kinases serve critical roles in signal transduction (44, 45) and the regulation of various cellular responses, including cell cycle progression, differentiation, inflammation, protein synthesis and proliferation (46) . There are five subtypes of acetylcholine muscarinic receptors (M 1 -M 5 ), of which three (M 1 , M 3 , and M 5 ) are coupled with PLC through a G q protein, whereas the other subtypes (M 2 and M 4 ) are able to inhibit adenylate cyclase via G o or G i proteins (47) . In various cellular systems, muscarinic receptor stimulation has been reported to activate MAPK (48, 49) . In the present study, the effects of m-PM on ICCs in the murine small intestine were investigated. m-PM modulated pacemaker activities in ICCs through muscarinic M 3 receptor activation via G protein, PLC and MAPK-dependent mechanisms. Therefore, ICCs are targets for m-PM and this interaction may improve intestinal motility.
In conclusion, Prunus mume Siebold & Zucc. was able to depolarize ICC pacemaker potentials in a G protein and MAPK-dependent manner by stimulating M 3 receptors. These findings suggest that Prunus mume Siebold & Zucc. may be developed as a potential gastroprokinetic agent for the treatment of GI motility disorders.
